109 related articles for article (PubMed ID: 9928024)
1. Coordinated role of vasoactive intestinal peptide and nitric oxide in cardioprotection.
Das DK; Kalfin R; Maulik N; Engelman RM
Ann N Y Acad Sci; 1998 Dec; 865():297-308. PubMed ID: 9928024
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological preconditioning with resveratrol: role of nitric oxide.
Hattori R; Otani H; Maulik N; Das DK
Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H1988-95. PubMed ID: 12003802
[TBL] [Abstract][Full Text] [Related]
3. Interplay between nitric oxide and vasoactive intestinal polypeptide in inducing fluid secretion in rat jejunum.
Mourad FH; Barada KA; Abdel-Malak N; Bou Rached NA; Khoury CI; Saade NE; Nassar CF
J Physiol; 2003 Aug; 550(Pt 3):863-71. PubMed ID: 12794180
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide--a retrograde messenger for carbon monoxide signaling in ischemic heart.
Maulik N; Engelman DT; Watanabe M; Engelman RM; Das DK
Mol Cell Biochem; 1996 Apr 12-26; 157(1-2):75-86. PubMed ID: 8739231
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide causes nitric oxide-dependent pulmonary vasodilation in isolated rat lung.
Iwabuchi S; Ono S; Tanita T; Koike K; Fujimura S
Respiration; 1997; 64(1):54-8. PubMed ID: 9044476
[TBL] [Abstract][Full Text] [Related]
6. Predominant role for nitric oxide in the relaxation induced by vasoactive intestinal polypeptide in human uterine artery.
Jovanović A; Jovanović S; Tulić I; Grbović L
Mol Hum Reprod; 1998 Jan; 4(1):71-6. PubMed ID: 9510014
[TBL] [Abstract][Full Text] [Related]
7. Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts--effects on regional myocardial flow and enzyme release.
Han H; Kaiser R; Hu K; Laser M; Ertl G; Bauersachs J
Basic Res Cardiol; 2003 May; 98(3):165-74. PubMed ID: 12883834
[TBL] [Abstract][Full Text] [Related]
8. Inducible nitric oxide synthase contributes to intermittent hypoxia against ischemia/reperfusion injury.
Ding HL; Zhu HF; Dong JW; Zhu WZ; Yang WW; Yang HT; Zhou ZN
Acta Pharmacol Sin; 2005 Mar; 26(3):315-22. PubMed ID: 15715927
[TBL] [Abstract][Full Text] [Related]
9. Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide.
Tosaki A; Maulik N; Elliott GT; Blasig IE; Engelman RM; Das DK
J Pharmacol Exp Ther; 1998 Jun; 285(3):1274-9. PubMed ID: 9618433
[TBL] [Abstract][Full Text] [Related]
10. Delayed 24 hours Nomega-nitro-L-arginine methyl ester injection induces pharmacological cardioprotection against reperfusion injury.
Davani S; Vergely C; Royer B; Bouhaddi M; Reyssie H; Rochette L; Kantelip JP
Cell Mol Biol (Noisy-le-grand); 2007 Jan; 52 Suppl():OL868-73. PubMed ID: 17543224
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of inducible nitric oxide in ischemia-reperfusion of rat small intestine.
Chen JC; Chen HM; Shyr MH; Fan LL; Chi TY; Chi CP; Chen MF
J Formos Med Assoc; 2000 Mar; 99(3):213-8. PubMed ID: 10820953
[TBL] [Abstract][Full Text] [Related]
12. Effects of VIP and NO on the motor activity of vascularly perfused rat proximal colon.
Kumano K; Fujimura M; Oshima S; Yamamoto H; Hayashi N; Nakamura T; Fujimiya M
Peptides; 2001 Jan; 22(1):91-8. PubMed ID: 11179602
[TBL] [Abstract][Full Text] [Related]
13. Effect of endogenous nitric oxide on cardiac systolic and diastolic function during ischemia and reperfusion in the rat isolated perfused heart.
Pabla R; Curtis MJ
J Mol Cell Cardiol; 1996 Oct; 28(10):2111-21. PubMed ID: 8930806
[TBL] [Abstract][Full Text] [Related]
14. Metabolic and functional protection by selective inhibition of nitric oxide synthase 2 during ischemia-reperfusion in isolated perfused hearts.
Ramasamy R; Hwang YC; Liu Y; Son NH; Ma N; Parkinson J; Sciacca R; Albala A; Edwards N; Szabolcs MJ; Cannon PJ
Circulation; 2004 Apr; 109(13):1668-73. PubMed ID: 15051645
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotection with pioglitazone is abolished by nitric oxide synthase inhibitor in ischemic rabbit hearts--comparison of the effects of pioglitazone and metformin.
Kawabata H; Ishikawa K
Diabetes Metab Res Rev; 2003; 19(4):299-305. PubMed ID: 12879407
[TBL] [Abstract][Full Text] [Related]
16. Myocardial vasoactive intestinal peptide and fibrosis induced by nitric oxide synthase inhibition in the rat.
Ye VZ; Hodge G; Yong JL; Duggan KA
Acta Physiol Scand; 2003 Dec; 179(4):353-60. PubMed ID: 14656372
[TBL] [Abstract][Full Text] [Related]
17. Endogenous protection against reperfusion-induced ventricular fibrillation: role of neuronal versus non-neuronal sources of nitric oxide and species dependence in the rat versus rabbit isolated heart.
Pabla R; Curtis MJ
J Mol Cell Cardiol; 1996 Oct; 28(10):2097-110. PubMed ID: 8930805
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
19. COX-2 and iNOS in opioid-induced delayed cardioprotection in the intact rat.
Patel HH; Hsu AK; Gross GJ
Life Sci; 2004 May; 75(2):129-40. PubMed ID: 15120566
[TBL] [Abstract][Full Text] [Related]
20. Protective role of intracoronary vasoactive intestinal peptide in ischemic and reperfused myocardium.
Kalfin R; Maulik N; Engelman RM; Cordis GA; Milenov K; Kasakov L; Das DK
J Pharmacol Exp Ther; 1994 Feb; 268(2):952-8. PubMed ID: 8114010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
